Introduction: Contextual Introduction Body: Highlight challenges, opportunities, and lessons learned from COVID-19 Conclusion: Way forward |
The ongoing mpox outbreak, declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO), underscores the urgent need for equitable access to vaccines in the Global South.
Contents
Challenges in Ensuring Equitable Access
- Inadequate Vaccine Production: The Global South continues to grapple with limited vaccine manufacturing capabilities, a challenge starkly highlighted during the COVID-19 pandemic. With only a small number of mpox vaccine doses currently available and a significant demand, the Global South risks being left behind once again.
- High Vaccine Costs: The estimated cost of a mpox vaccine shot at $100 presents a formidable barrier to access in low- and middle-income countries (LMICs). This economic disparity further exacerbates the unequal distribution of vaccines.
- Delayed Technology Transfers: Effective and timely technology transfers are crucial for scaling up vaccine production in the Global South. However, historical precedents show that delays in the transfer of know-how, patents, and biological resources have hampered equitable access to vaccines.
Opportunities to Improve Access
- Leveraging Existing Manufacturing Capabilities: Indian manufacturers, such as the Serum Institute of India and Bharat Biotech, have the potential to play a pivotal role in scaling up the production of the MVA-BN vaccine.
- Regulatory Flexibility: The recent decision by India’s drug regulatory agency to waive clinical trial requirements for drugs approved in other countries represents a significant step toward expediting vaccine availability.
Applying Lessons from COVID-19
- Investment in Local Manufacturing: Strengthening vaccine production capabilities in the Global South is essential to avoid the pitfalls of dependency seen during the COVID-19 pandemic.
- Equity as a Core Principle: The inclusion of equity in the recent amendments to the International Health Regulations (IHR) highlights the importance of ensuring that the global response is rooted in fairness and inclusivity.
Conclusion
While the mpox outbreak presents significant challenges, it also offers an opportunity to apply the hard-earned lessons from the COVID-19 pandemic. By fostering global cooperation, prioritizing technology transfers, and leveraging the manufacturing capabilities of countries like India, the world can take decisive steps toward ensuring equitable access to vaccines and improving global health equity. The time to act is now before history repeats itself.